Form 4: Intuitive Surgical Executive Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
An Intuitive Surgical executive, Robert DeSantis, executed a pre-planned sale of company stock and options under a 10b5-1 trading plan.
Summary
- Robert DeSantis, an Executive Vice President at Intuitive Surgical, sold 198 shares of common stock at $542.06 per share on November 26, 2024.
- He also exercised options to acquire 198 shares at $245.6 and 198 shares at $347.4167, and then sold those shares at $542.06 each.
- These transactions were conducted under a pre-arranged 10b5-1 trading plan.
- The trading plan is set to expire on December 9, 2024.
- Following these transactions, DeSantis directly owns 5,506 shares of Intuitive Surgical stock and 597 non-qualified stock options at each of the two exercise prices.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of insider trading activity, which is neither positive nor negative for the company's overall performance. It is a neutral event.
Industry Context
This is a routine disclosure of insider trading activity, which is common for executives of publicly traded companies. The use of a 10b5-1 plan indicates that the transactions were pre-planned and not based on any non-public information.
Comparison to Industry Standards
- The use of 10b5-1 trading plans is a standard practice among executives at publicly traded companies like Intuitive Surgical, including competitors such as Medtronic and Stryker.
- These plans allow executives to sell shares without being accused of insider trading, as the trades are pre-scheduled and not based on current market information.
- The reported transactions are typical in terms of volume and price for executive stock sales.
Stakeholder Impact
- The stock sale by an executive may have a minor impact on shareholder sentiment, but it is unlikely to significantly affect the company's stock price due to the pre-planned nature of the transactions.
Key Dates
| Date | Description |
|---|---|
| 11/26/2024 | Date of stock and option transactions. |
| 12/09/2024 | Expiration date of the 10b5-1 trading plan. |
| 02/26/2031 | Expiration date of one set of non-statutory stock options. |
| 08/26/2031 | Expiration date of another set of non-statutory stock options. |
Keywords
Intuitive Surgical, Robert DeSantis, stock sale, 10b5-1 trading plan, executive stock options, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.